Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112167583 | 11216758 | 3 | F | 201504 | 20160726 | 20150624 | 20160808 | EXP | DK-DKMA-EFO12215 | DK-PFIZER INC-2015207035 | PFIZER | 57.00 | YR | M | Y | 90.00000 | KG | 20160808 | MD | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112167583 | 11216758 | 1 | PS | LOPID | GEMFIBROZIL | 1 | Oral | 600 MG, 2X/DAY | 18422 | 600 | MG | BID | |||||||
| 112167583 | 11216758 | 2 | I | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, 2X/DAY | Y | 0 | 500 | MG | BID | ||||||
| 112167583 | 11216758 | 3 | I | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 60 MG, 1X/DAY | Y | 0 | 60 | MG | QD | ||||||
| 112167583 | 11216758 | 4 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 50 MG, 1X/DAY | 0 | 50 | MG | QD | |||||||
| 112167583 | 11216758 | 5 | C | CLORIOCARD | 2 | 75 MG, UNK | 0 | 75 | MG | ||||||||||
| 112167583 | 11216758 | 6 | C | DOLOL RETARD UNO | TRAMADOL | 1 | 150 MG, 2X/DAY | 0 | 150 | MG | BID | ||||||||
| 112167583 | 11216758 | 7 | C | HJERTEMAGNYL /00228701/ | ASPIRINMAGNESIUM OXIDE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD | ||||||||
| 112167583 | 11216758 | 8 | C | ISOSORBIDE DINITRATE. | ISOSORBIDE DINITRATE | 1 | 30 MG, 2X/DAY | 0 | 30 | MG | BID | ||||||||
| 112167583 | 11216758 | 9 | C | IBUMETIN | IBUPROFEN | 1 | 600 MG, 2X/DAY | 0 | 600 | MG | BID | ||||||||
| 112167583 | 11216758 | 10 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | BID | ||||||||
| 112167583 | 11216758 | 11 | C | PANODIL | ACETAMINOPHEN | 1 | 2 G, 2X/DAY | 0 | 2 | G | BID | ||||||||
| 112167583 | 11216758 | 12 | C | VICTOZA | LIRAGLUTIDE | 1 | 1.2 MG, UNK | 0 | 1.2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112167583 | 11216758 | 1 | Hyperlipidaemia |
| 112167583 | 11216758 | 2 | Pneumonia |
| 112167583 | 11216758 | 3 | Hyperlipidaemia |
| 112167583 | 11216758 | 4 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112167583 | 11216758 | LT |
| 112167583 | 11216758 | OT |
| 112167583 | 11216758 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112167583 | 11216758 | Abdominal pain | |
| 112167583 | 11216758 | Alanine aminotransferase increased | |
| 112167583 | 11216758 | Aspartate aminotransferase increased | |
| 112167583 | 11216758 | Back pain | |
| 112167583 | 11216758 | Blood creatine phosphokinase increased | |
| 112167583 | 11216758 | Blood lactate dehydrogenase increased | |
| 112167583 | 11216758 | Drug interaction | |
| 112167583 | 11216758 | Haematuria | |
| 112167583 | 11216758 | Myalgia | |
| 112167583 | 11216758 | Myoglobin blood increased | |
| 112167583 | 11216758 | Pneumonia | |
| 112167583 | 11216758 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112167583 | 11216758 | 1 | 201106 | 0 | ||
| 112167583 | 11216758 | 2 | 20150424 | 20150429 | 0 | |
| 112167583 | 11216758 | 3 | 2011 | 20150429 | 0 | |
| 112167583 | 11216758 | 4 | 20110601 | 0 |